Read the article here: Point-of-care sensors for the management of sepsis
Science
Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.
Research & Development
NOSIS™
Partners
Evidence
The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers
Read More →
Platform
Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.
Sepsis ImmunoScore®
Clinical Trials
Pipeline
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Resources
Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.
Newsroom
Resource Library
Events
Why We Call It an “AI-Biomarker”
Read More →
Newsroom
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore Outperforms Conventional Sepsis Tools
Read More →
About
As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.
Mission, Vision & Values
Careers
Leadership
Investors
Awards
Prenosis and Winners of the Chicago Innovation Awards Ring the Opening Nasdaq Bell
Read More →